The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
73030596 7303059 6 F 200911 20160915 20100303 20160919 EXP US-NAPPMUNDI-USA-2010-0042351 PURDUE 71.46 YR M Y 90.70000 KG 20160916 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
73030596 7303059 1 PS MS CONTIN MORPHINE SULFATE 1 Oral 15 MG, TID UNKNOWN 19516 15 MG PROLONGED-RELEASE TABLET
73030596 7303059 2 SS MS CONTIN MORPHINE SULFATE 1 19516 PROLONGED-RELEASE TABLET
73030596 7303059 3 SS Blinded therapy INVESTIGATIONAL PRODUCT 1 Oral UNK D UNKNOWN 0
73030596 7303059 4 SS Blinded therapy INVESTIGATIONAL PRODUCT 1 D 0
73030596 7303059 5 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 UNK 0
73030596 7303059 6 C DARVON PROPOXYPHENE HYDROCHLORIDE 1 UNK 0
73030596 7303059 7 C TRENTAL PENTOXIFYLLINE 1 UNK 0
73030596 7303059 8 C TRAMADOL. TRAMADOL 1 UNK 0
73030596 7303059 9 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 UNK 0
73030596 7303059 10 C INDERAL PROPRANOLOL HYDROCHLORIDE 1 UNK 0
73030596 7303059 11 C CRESTOR ROSUVASTATIN CALCIUM 1 UNK 0
73030596 7303059 12 C ZOLOFT SERTRALINE HYDROCHLORIDE 1 UNK 0
73030596 7303059 13 C LASIX FUROSEMIDE 1 UNK 0
73030596 7303059 14 C ASPIRIN. ASPIRIN 1 UNK 0
73030596 7303059 15 C LOTREL AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE 1 UNK 0
73030596 7303059 16 C FOSAMAX ALENDRONATE SODIUM 1 UNK 0
73030596 7303059 17 C CYCLOBENZAPRINE HYDROCHLORIDE. CYCLOBENZAPRINE HYDROCHLORIDE 1 UNK UNKNOWN 0
73030596 7303059 18 C OXYGEN. OXYGEN 1 UNK 0
73030596 7303059 19 C MSIR Capsules MORPHINE SULFATE 1 UNK U 19516 CAPSULE, HARD
73030596 7303059 20 C DEPAKOTE DIVALPROEX SODIUM 1 UNK 0
73030596 7303059 21 C HYOSCYAMINE. HYOSCYAMINE 1 UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
73030596 7303059 1 Osteoarthritis
73030596 7303059 2 Neck pain
73030596 7303059 3 Osteoarthritis
73030596 7303059 4 Rheumatoid arthritis
73030596 7303059 21 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
73030596 7303059 HO
73030596 7303059 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
73030596 7303059 Musculoskeletal chest pain
73030596 7303059 Pericardial effusion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
73030596 7303059 1 20080305 0
73030596 7303059 3 20080121 20101112 0
73030596 7303059 5 20010820 0
73030596 7303059 6 19930106 0
73030596 7303059 7 19950118 0
73030596 7303059 8 19970415 0
73030596 7303059 9 19921209 0
73030596 7303059 10 19941213 0
73030596 7303059 11 20040128 0
73030596 7303059 12 20031208 0
73030596 7303059 13 20030815 0
73030596 7303059 14 1993 0
73030596 7303059 15 20030821 0
73030596 7303059 16 20040512 0
73030596 7303059 17 20080206 0
73030596 7303059 18 20080517 0
73030596 7303059 19 20080305 0
73030596 7303059 20 20080527 0
73030596 7303059 21 20000203 0